|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Atherosclerosis and interferon-γ: New insights and therapeutic targets显示文摘 | Voloshyna Iryna Michael J. Littlefield Allison B. Reiss | 2013 | Trends in Cardiovascular Medicine2013，，： | 2 |
| 2 | particular features of fatty acids composition of low density lipiproteids in patients with metabolic syndrome 显示文摘 | Lyzohub VH Voloshyna OO Briuzhina TS | 2007 | Lik Sprava2007，7，71： | 1 |
| 3 | Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine显示文摘 | Voloshyna I Hai O Littlefield M J | 2013 | Eur J Pharma- col2013，698，13： | 1 |
| 4 | Regulation of cerebral cholesterol metabolism in Alzheimer disease显示文摘 | Reiss AB Voloshyna I | 2012 | J Investig Med2012，60，57： | 1 |
| 5 | A, B, or C? Experimental Tests of IPO Mechanisms 显示文摘 | Bonini S Voloshyna O | 2011 | European Financial Management2011，17，5： | 1 |
| 6 | Particular features of fatty acids composition of low density lipiproteids in patients with metabolic syndrome 显示文摘 | Lyzohub VH Voloshyna OO Briuzhina TS | 2007 | Lik Sprava2007，7，71： | 1 |
| 7 | TREK-1 is a novel molecular target in pros- tate cancer显示文摘 | Voloshyna I Besana A Castillo M | 2008 | Cancer Res2008，68，： | 1 |
| 8 | Particular features of fatty acids composition of low density lipiproteids in patients with metabolic syndrome显示文摘 | Lyzohub VH Voloshyna OO Briuzhina TS | 2007 | Lik Sprava2007，7，71： | 1 |
| 9 | A, B, or C? Experimental tests of IPO mechanisms 显示文摘 | Bonini S Voloshyna O | 2011 | European Financial Manage- ment2011，17，5： | 1 |
| 10 | TREK-1 is a novel molecular target in prostate cancer显示文摘 | Iryna Voloshyna Alessandra Besana Mireia Castillo | 2008 | Cancer Res2008，68，： | 1 |
| 11 | TREK-1 is a novel molecular target in prostate cancer显示文摘 | Voloshyna I Besana A Castillo M | 2008 | Cancer Res2008，68，： | 1 |
| 12 | Regulation of cerebral cholesterol metabo- lism in Alzheimer' S disease 显示文摘 | Reiss AB Voloshyna I | 2012 | J Investig Med2012，60，3： | 1 |
| 13 | Resveratrol mediates anti-atherogenic effects on cholesterol flux in human maerophages and endothelium via PPAR gamma and adenosine 显示文摘 | Voloshyna I Hal O Littlefleld M J | 2013 | Eur J Phar- macol2013，698，13： | 1 |
| 14 | TREK-1 is a novel molecular target in prostate cancer显示文摘 | Voloshyna I Besana A Castillo M | 2008 | Cancer Res2008，68，4： | 1 |
| 15 | 12-Lipoxy-genase regulates hippocampal long-term potentiation by modulating L-type Ca^2+ channels显示文摘 | DeCostanzo A J Voloshyna I Rosen Z B | 2010 | J Neurosci2010，30，5： | 1 |
| 16 | Regulation of cerebral cholesterol metabolism in Alzheimer's disease显示文摘 | Reiss AB Voloshyna I | 2012 | J Investig Med2012，60，3： | 1 |
| 17 | Regulation of cerebral cholesterol metabolism in Alzheimer disease 显示文摘 | REISS A B VOLOSHYNA I | 2012 | J Invest Med2012，60，3： | 1 |
| 18 | Linear Hexane Isomerization over the Natural Zeolite Based Cata-lysts Depending on the Zeolite Phase Composition显示文摘 | Patrylak K I Bobonych F M Voloshyna Y G | 2001 | Catal Today2001，65，24： | 1 |
| 19 | Resveratrol in cholesterol metabolism and atherosclerosis 显示文摘 | Voloshyna I Hussaini SM Reiss AB | 2012 | J Med Food2012，15，9： | 1 |
| 20 | Role of leptin in the progression of psoriatic,rheumatoid and osteoarthritis显示文摘Leptin,an adipokine responsible for body weight regulation,may be involved in pathological processesrelated to inflammation in joint disorders including rheumatoid arthritis(RA),osteoarthritis,and psoriatic arthritis(PsA).These arthropathies have been associated with a wide range of systemic and inflammatory con-ditions including cardiovascular disease,obesity,and metabolic syndrome.As a potent mediator of immune responses,leptin has been found in some studies to play a role in these disorders.Furthermore,current potent biologic treatments effectively used in Ps A including ustekinumab(an interleukin 12/23 blocker) and ada-limumab(a tumor necrosis factor-alpha blocker also used in RA) have been found to increase leptin receptor expression in human macrophages.This literature review aims to further investigate the role leptin may play in the disease activity of these arthropathies. | Jessica Mounessa Iryna Voloshyna Amy D Glass Allison B Reiss | 2016 | World Journal of Rheumatology2016，6，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员